Navigation Links
MIT nanoparticles may help detect, treat tumors

A new technique devised by MIT engineers may one day help physicians detect cancerous tumors during early stages of growth.

The technique allows nanoparticles to group together inside cancerous tumors, creating masses with enough of a magnetic signal to be detectable by a magnetic resonance imaging (MRI) machine.

The work appears as the cover feature in the May issue of Angewandte Chemie International Edition, one of the world's leading chemistry journals.

The research, which is just moving into animal testing, involves injecting nanoparticles (billionths of a meter in size) made of iron oxide into the body, where they flow through the bloodstream and enter tumors.

Solid tumors must form new blood vessels to grow. But because this growth is so rapid in cancerous tumors, there are gaps in the endothelial cells that line the inside of the blood vessels. The nanoparticles can slip through these gaps to enter the tumors.

Once inside the tumor, the nanoparticles can be triggered to group together by a mechanism designed by the MIT engineers. Specifically, certain enzymes, or proteases, inside the tumors cause the nanoparticles to "self-assemble" or stick together. The resulting nanoparticle clumps are too big to get back out of the gaps. Further, the clumps have a stronger magnetic signal than do individual nanoparticles, allowing detection by MRI.

"We inject nanoparticles that will self-assemble when they are exposed to proteases inside of invasive tumors," said Sangeeta N. Bhatia, M.D., Ph.D., associate professor of the Harvard-MIT Division of Health Sciences & Technology (HST) and Electrical Engineering and Computer Science (EECS). "When they assemble they should get stuck inside the tumor and be more visible on an MRI. This might allow for noninvasive imaging of fast-growing cancer 'hot spots' in tumors." Bhatia also is affiliated with the MIT-Harvard Center of Cancer Nanotechnology Excellence.

The technique
'"/>

Source:Massachusetts Institute of Technology


Page: 1 2

Related biology news :

1. Probing the promise and perils of nanoparticles
2. Novel gene-silencing nanoparticles shown to inhibit Ewings sarcoma
3. Using nanoparticles, in vivo gene therapy activates brain stem cells
4. NJIT study shows nanoparticles could damage plant life
5. Gold nanoparticles could improve antisense cancer drugs
6. Quantum dots reviewed -- Could these nanoparticles hold the cure to cancer?
7. Electric jolt triggers release of biomolecules, nanoparticles
8. U-M researchers use nanoparticles to target brain cancer
9. Gold nanoparticles prove to be hot stuff
10. Widely used iron nanoparticles exhibit toxic effects on neuronal cells
11. Coated nanoparticles solve sticky drug-delivery problem
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: MIT nanoparticles may help detect treat tumors

(Date:4/20/2015)... 2015 The announcement comes as ... Records Management (GRM), Ireland,s foremost records ... Having built up an impressive track record of clients within ... within the records management sector in Dubai ... GCC staffbase and employ a further eight staff members at ...
(Date:4/14/2015)... YORK , April 14, 2015  HYPR ... IDentity Online (FIDO ® ) Alliance tm , ... specifications. FIDO members commit to share technology and ... methods that are interoperable, more secure and private, ... enable biometric identity verification that protects sensitive user ...
(Date:4/13/2015)... 2015 According to a ... Market Forecast & Opportunities, 2020", the global biometrics market ... 14% till 2020. The biometrics market is garnering ... and review of biometric management systems. The constant ... with greater efficiency, are resulting in increasing installation ...
Breaking Biology News(10 mins):Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2
... E supplements may blunt the improvement of muscular endurance ... new study published today [3 February] in The Journal ... widely used, understanding if they interfere with cellular and physiological ... health purposes as well as to athletes., Dr Gran Paulsen, ...
... Immune cells undergo ,spontaneous, changes on a daily basis ... diligent surveillance of our immune system, Melbourne scientists have ... Eliza Hall Institute found that the immune system was ... their early stages, before they developed into B-cell lymphomas ...
... In many people with autism and other neurodevelopmental disorders, ... other very well. Scientists have now identified, for the ... connectivity can come about. In a study published online ... European Molecular Biology Laboratory (EMBL) in Monterotondo, Italy, and ...
Cached Biology News:Vitamin C and E supplements hampers endurance training 2Red alert: Body kills 'spontaneous' blood cancers on a daily basis 2Making your brain social 2
(Date:5/26/2015)... Miami, FL (PRWEB) May 26, 2015 ... training, Inc. have announced plans for the company’s first ... 9, 2015, followed by a full day, hands-on stem ... hosted by J. Victor Garcia Gimenez, M.D., President of ... to the medical community’s increasing interest in regenerative medicine ...
(Date:5/26/2015)... ORANGEBURG, N.Y. , May 26, 2015 /PRNewswire/ ... products and solutions, today announced that Oakwood Healthcare ... been selected as the winning entry in ... recognizing industry professionals who display excellence in building ... services (ES) teams in healthcare facilities.  ...
(Date:5/26/2015)... ANGELES , May 26, 2015 Pharmaco-Kinesis ... Board (NOCAB) recently convened at Shutters on the Beach ... review the development status of the Company,s innovative Metronomic ... designed to locally deliver chemotherapy over time to a ... dose delivery capacity and biofeedback system in real-time.  ...
(Date:5/26/2015)... 2015 Kevin Xu , prezident ... Barackovi Obamovi a Billovi Clintonovi za ich kondolencie ... Rongxiang Xu , otca Kevina. ... Dr. Xu bol pionier, inovátor, humanitárny pracovník a ... oblasti vedy a príkladné vedenie svojej komunity zanecháva ...
Breaking Biology Technology:Stem Cell Training, Inc. Announces First European Symposium on Cellular and Regenerative Medicine 2Stem Cell Training, Inc. Announces First European Symposium on Cellular and Regenerative Medicine 3PDI Announces Winner in Delivering the Difference Contest 2PDI Announces Winner in Delivering the Difference Contest 3Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 2Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 3Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 4Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 5Dr. Rongxiang Xu, O legende 2
... 16 /PRNewswire-Asia-FirstCall/ -- A-Power Energy,Generation Systems, Ltd. (Nasdaq: ... of distributed power generation ("DG") systems in China and ... signed a,contract with Sanmenxia New Energy Bio-Electricity Co., Ltd. ... Province of,China. , Pursuant to ...
... SYDNEY, June 16 /PRNewswire-Asia/ -- Pharmaceutical company ... announce that additional results of its,recently completed international Phase III ... at the 2009 European Cystic Fibrosis,Conference in Brest, France. , ... conference on Friday 12 June by Dr Diana,Bilton of the ...
... Sharoky, M.D. to Assume the Role of Chairman of the ... Insmed Inc. (Nasdaq: INSM ), a biopharmaceutical company, ... President, Chief Executive Officer and Chairman of the Board of ... Allan has served as Insmed,s President, Chief Executive Officer and ...
Cached Biology Technology:A-Power Energy Generation Systems Ltd. Signs a Biomass-Based DG Contract with Sanmenxia New Energy Bio-Electricity Co., Ltd. 2A-Power Energy Generation Systems Ltd. Signs a Biomass-Based DG Contract with Sanmenxia New Energy Bio-Electricity Co., Ltd. 3Phase 3 Cystic Fibrosis Trial Results Presented at European Conference 2Phase 3 Cystic Fibrosis Trial Results Presented at European Conference 3Phase 3 Cystic Fibrosis Trial Results Presented at European Conference 4Insmed CEO Resigns Due to Health Concerns 2Insmed CEO Resigns Due to Health Concerns 3